1583. Eight Years of Sustained Potency and Activity of Oritavancin against Gram-Positive Isolates Causing Bacteremia and Endocarditis in the USA, Including Enterococcal Infections Requiring an Optimized Dosing Strategy for Daptomycin

BACKGROUND: Oritavancin (ORI) is a potent lipoglycopeptide with desirable PK/PD parameters for treating serious gram-positive infections. This study assessed the activity of ORI against Staphylococcus aureus (SA), Enterococcus faecalis (EF), and E. faecium (EFM) causing bloodstream infection (BSI),...

Descripción completa

Detalles Bibliográficos
Autores principales: Carvalhaes, Cecilia G, Sader, Helio S, Streit, Jennifer M, Flamm, Robert K, Mendes, Rodrigo E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810100/
http://dx.doi.org/10.1093/ofid/ofz360.1447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810100/
http://dx.doi.org/10.1093/ofid/ofz360.1447

Ejemplares similares